Prion protein expression and processing in human mononuclear cells: The impact of the codon 129 prion gene polymorphism

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Segarra, Christiane ^a   Lehmann, Sylvain ^b   Coste, Joliette ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PRION PROTEIN; VALINE;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; VARIANT CREUTZFELDT JAKOB DISEASE; BIOSYNTHESIS; BRAIN; CHEMISTRY; CODON; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HOMOZYGOTE; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; PRION; PRION DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BOVINE SPONGIFORM ENCEPHALOPATHY PRION;

BRAIN; CODON; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; IMMUNOBLOTTING; LEUKOCYTES, MONONUCLEAR; METHIONINE; POLYMORPHISM, GENETIC; PRION DISEASES; PRIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VALINE;

EID: 67149094724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005796     Document Type: Article

References (59)

1. Pocchiari M (1994) Prions and related neurological diseases. Mol Aspects Med 15: 195-291.
2. Prusiner SB (1993) Genetic and infectious prion diseases. Arch Neurol 50: 1129-53.
3. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921-5.
4. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95: 13363-83.
5. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, et al. (1993) Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32: 1991-2002.
6. Turk E, Teplow DB, Hood LE, Prusiner SB (1988) Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem 176: 21-30.
7. Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28: 8380-8.
8. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, et al. (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 274: 1-13.
9. Stahl N, Baldwin MA, Hecker R, Pan KM, Burlingame AL, et al. (1992) Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31: 5043-53.
10. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, et al. (1991) Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30: 7672-80.
11. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90: 10962-6.
12. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr (1993) Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 268: 20276-84.
13. Moroncini G, Kanu N, Solforosi L, Abalos G, Telling GC, et al. (2004) Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proc Natl Acad Sci U S A 101: 10404-9.
14. Cohen FE, Prusiner SB (1998) Pathologic conformations of prion proteins. Annu Rev Biochem 67: 793-819.
15. Caughey B, Raymond GJ, Callahan MA, Wong C, Baron GS, et al. (2001) Interactions and conversions of prion protein isoforms. Adv Protein Chem 57: 139-69.
16. Taraboulos A, Rogers M, Borchelt DR, McKinley MP, Scott M, et al. (1990) Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc Natl Acad Sci U S A 87: 8262-6.
17. Lehmann S, Harris DA (1997) Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem 272: 21479-87.
18. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, et al. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270: 19173-80.
19. Pan T, Wong P, Chang B, Li C, Li R, et al. (2005) Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J Virol 79: 934-43.
20. Lee IY, Westaway D, Smit AF, Wang K, Seto J, et al. (1998) Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res 8: 1022-37.
21. Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, et al. (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353: 1673-4.
22. No author (2001) Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. 157: 633-7.
23. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ (1986) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122: 1-5.
24. Moser M, Colello RJ, Pott U, Oesch B (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14: 509-17.
25. Peden AH, Ritchie DL, Head MW, Ironside JW (2006) Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168: 927-35.
26. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, et al. (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353: 183-9.
27. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J (1998) Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352: 703-4.
28. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, et al. (1997) A crucial role for B cells in neuroinvasive scrapie. Nature 390: 687-90.
29. Klein MA, Frigg R, Raeber AJ, Flechsig E, Hegyi I, et al. (1998) PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 4: 1429-33.
30. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356: 999-1000.
31. Pincock S (2004) Patient's death from vCJD may be linked to blood transfusion. Committee to discuss need for further precautions to prevent possible vCJD transmission through blood. Lancet 363: 43.
32. Pincock S (2004) Government confirms second case of vCJD transmitted by blood transfusion. Bmj 329: 251.
33. Turner ML, Ludlam CA (2009) An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol 144: 14-23.
34. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, et al. (2006) Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Bmj 332: 1186-8.
35. Harris DA, Huber MT, van Dijken P, Shyng SL, Chait BT, et al. (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 32: 1009-16.
36. Barclay GR, Houston EF, Halliday SI, Farquhar CF, Turner ML (2002) Comparative analysis of normal prion protein expression on human, rodent, and ruminant blood cells by using a panel of prion antibodies. Transfusion 42: 517-26.
37. Barclay GR, Hope J, Birkett CR, Turner ML (1999) Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry. Br J Haematol 107: 804-14.
38. Dodelet VC, Cashman NR (1998) Prion protein expression in human leukocyte differentiation. Blood 91: 1556-61.
39. Teupser D, Heino N, Wilfert W, Thiery J (2002) Rapid detection of the prion protein M129V polymorphism with the LightCycler. J Neurosci Methods 115: 93-6.
40. Simak J, Holada K, D'Agnillo F, Janota J, Vostal JG (2002) Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 42: 334-42.
41. Starke R, Drummond O, MacGregor I, Biggerstaff J, Gale R, et al. (2002) The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? Br J Haematol 119: 863-73.
42. Vega A, Ruiz-Ponte C, Carracedo A, Barros F (2001) Rapid genotyping of the M129V polymorphism of prion protein using real-time fluorescent PCR. Clin Chem 47: 1874-5.
43. Lucotte G, Mercier G (2005) The population distribution of the Met allele at the PRNP129 polymorphism (a high risk factor for Creutzfeldt-Jakob disease) in various regions of France and in West Europe. Infect Genet Evol 5: 141-4.
44. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, et al. (1993) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A 90: 10608-12.
45. Lee SC, Antony A, Lee N, Leibow J, Yang JQ, et al. (2000) Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol 38: 4171-9.
46. Xiang W, Windl O, Wunsch G, Dugas M, Kohlmann A, et al. (2004) Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol 78: 11051-60.
47. Riemer C, Neidhold S, Burwinkel M, Schwarz A, Schultz J, et al. (2004) Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun 323: 556-64.
48. Baker CA, Manuelidis L (2003) Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 100: 675-9.
49. Baker CA, Lu ZY, Manuelidis L (2004) Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease. J Neurovirol 10: 29-40.
50. Volkel D, Zimmermann K, Zerr I, Bodemer M, Lindner T, et al. (2001) Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 41: 441-8.
51. Halliday S, Houston F, Hunter N (2005) Expression of PrPC on cellular components of sheep blood. J Gen Virol 86: 1571-9.
52. Mange A, Beranger F, Peoc'h K, Onodera T, Frobert Y, et al. (2004) Alpha- and beta- cleavages of the amino-terminus of the cellular prion protein. Biol Cell 96: 125-32.
53. Grassi J, Maillet S, Simon S, Morel N (2008) Progress and limits of TSE diagnostic tools. Vet Res 39: 33.
54. Gonzalez-Romero D, Barria MA, Leon P, Morales R, Soto C (2008) Detection of infectious prions in urine. FEBS Lett 582: 3161-6.
55. Alonso DO, DeArmond SJ, Cohen FE, Daggett V (2001) Mapping the early steps in the pH-induced conformational conversion of the prion protein. Proc Natl Acad Sci U S A 98: 2985-9.
56. Hosszu LL, Jackson GS, Trevitt CR, Jones S, Batchelor M, et al. (2004) The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J Biol Chem 279: 28515-21.
57. Shamsir MS, Dalby AR (2005) One gene, two diseases and three conformations: molecular dynamics simulations of mutants of human prion protein at room temperature and elevated temperatures. Proteins 59: 275-90.
58. Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, et al. (2003) Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362: 128-30.
59. Huillard d'Aignaux J, Costagliola D, Maccario J, Billette de Villemeur T, Brandel JP, et al. (1999) Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 53: 1197-201.